UK poll finds executives believe US will rule biotech again.
An international annual survey has found that the United States is expected to increase its lead in biotechnology. UK law firm Marks & Clerk polled 365 executives in the drug, biotechnology, higher-education and venture-capital sectors. President Barack Obama's initiatives will boost the US position as a centre for the industry, said 85%. This threatens the role of Europe, despite problems in US biotech (see Nature 459, 467; 2009). Co-author Paul Chapman, a partner in the firm, says the United States is showing new support for regenerative medicine and potential acceptance of stem-cell research. “Europe and the UK cannot afford to watch from the sidelines,” he says in the report.
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
US to dominate biotech?. Nature 459, 603 (2009). https://doi.org/10.1038/nj7246-603d
Published:
Issue Date:
DOI: https://doi.org/10.1038/nj7246-603d